Dr. Neil Kay is a Professor of Medicine, a Staff Consultant and a Career Scientist in the Division of Hematology, Department of Medicine at the Mayo Clinic. His medical subspecialty experience is in the field of Hematology and he has primarily focused on the study of B CLL. This work has led to national and international recognition of the Mayo Clinic CLL research program. He is also a member of the Eastern Cooperative Oncology Group where he is a core leukemia committee member and is a member of the National Cancer Institute leukemia steering committee. He is known for his clinical and biologic research in B cell hematologic malignancies where he focuses on the genetic features of CLL B cells, immunologic status of the CLL patient, interactions of CLL B cells with its microenvironment, clinical and biologic aspects of monoclonal B cell lymphocytosis and the development and conduct of unique clinical trials for early stage and upfront progressive CLL.